Receptors involved in the oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero3-phosphorylcholine-mediated synthesis of interleukin-8 -: A role for toll-like receptor 4 and a glycosylphosphatidylinositol-anchored protein

被引:139
作者
Walton, KA
Hsieh, X
Gharavi, N
Wang, S
Wang, G
Yeh, M
Cole, AL
Berliner, JA
机构
[1] Univ Calif Los Angeles, Ctr Hlth Sci Pathol 13 229, Dept Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90095 USA
关键词
D O I
10.1074/jbc.M300738200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We demonstrated previously that oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (ox-PAPC) and, specifically, the component lipid 1-palmitoyl-2-(5,6-epoxyisoprostane E-2)-sn-glycero-3-phosphorylcholine increase interleukin-8 (IL-8) synthesis in aortic endothelial cells. The goal of the current studies was to characterize the receptor complex mediating the increased transcription of IL-8. We demonstrate that scavenger receptor class A, types I and II, lectin-like ox-LDL receptor-1, macrophage receptor with collagenous structure, and CD36 are not responsible for the increase in IL-8. Using dominant-negative constructs and antisense oligonucleotides, we demonstrate a role for Toll-like receptor 4 (TLR4) as the ox-PAPC receptor mediating IL-8 transcription. We demonstrate that a glycosylphosphatidylinositol (GPI)-anchored protein is also necessary because phosphatidylinositol-specific phospholipase C pretreatment inhibited the effect of ox-PAPC. CD14, a GPI-anchored protein that associates with TLR4 in mediating lipopolysaccharide action, did not appear to mediate ox-PAPC action because ox-PAPC-induced IL-8 transcription was not blocked by anti-CD14 neutralizing antibodies nor was it augmented by the addition of soluble CD14 or overexpression of membrane CD14. Instead, anti-TLR4 antibodies immunoprecipitated a 37-kDa protein that also bound ox-PAPC. A protein of this same size was found in aerolysin overlays used to detect GPI-anchored proteins. Therefore, these studies suggest that ox-PAPC may initially bind to a 37-kDa GPI-anchored protein, which interacts with TLR4 to induce IL-8 transcription.
引用
收藏
页码:29661 / 29666
页数:6
相关论文
共 35 条
[1]  
Boullier A, 2001, ANN NY ACAD SCI, V947, P214
[2]   Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction [J].
Chow, JC ;
Young, DW ;
Golenbock, DT ;
Christ, WJ ;
Gusovsky, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (16) :10689-10692
[3]  
COLOTTA F, 1984, J IMMUNOL, V132, P936
[4]   Macrophage scavenger receptor class A - A multifunctional receptor in atherosclerosis [J].
de Winther, MPJ ;
van Dijk, KW ;
Havekes, LM ;
Hofker, MH .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (02) :290-297
[5]   Scavenger receptors and oxidized low density lipoproteins [J].
Dhaliwal, BS ;
Steinbrecher, UP .
CLINICA CHIMICA ACTA, 1999, 286 (1-2) :191-205
[6]   Expression of toll-like receptors in human atherosclerotic lesions - A possible pathway for plaque activation [J].
Edfeldt, K ;
Swedenborg, J ;
Hansson, GK ;
Yan, ZQ .
CIRCULATION, 2002, 105 (10) :1158-1161
[7]   CLONING OF A NOVEL BACTERIA-BINDING RECEPTOR STRUCTURALLY RELATED TO SCAVENGER RECEPTORS AND EXPRESSED IN A SUBSET OF MACROPHAGES [J].
ELOMAA, O ;
KANGAS, M ;
SAHLBERG, C ;
TUUKKANEN, J ;
SORMUNEN, R ;
LIAKKA, A ;
THESLEFF, I ;
KRAAL, G ;
TRYGGVASON, K .
CELL, 1995, 80 (04) :603-609
[8]   Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice [J].
Febbraio, M ;
Podrez, EA ;
Smith, JD ;
Hajjar, DP ;
Hazen, SL ;
Hoff, HF ;
Sharma, K ;
Silverstein, RL .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (08) :1049-1056
[9]   Differential roles of CD36 and αvβ5 integrin in photoreceptor phagocytosis by the retinal pigment epithelium [J].
Finneman, SC ;
Silverstein, RL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (09) :1289-1298
[10]   Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium [J].
Frantz, S ;
Kobzik, L ;
Kim, YD ;
Fukazawa, R ;
Medzhitov, R ;
Lee, RT ;
Kelly, RA .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (03) :271-280